Journal of Clinical Lipidology
Volume 4, Issue 3 , Pages 185-195 , May 2010

Prevalence of metabolic syndrome and insulin resistance among Egyptian adolescents 10 to 18 years of age

Received 21 October 2009 ,Accepted 11 March 2010.

References 

  1. Brown DW, Mokdad AH, Henry Walke W, et al. MD projected burden of chronic, noncommunicable diseases in Jordan. Prev Chronic Dis. 2009;6:A78
  2. WHO. Diet, Nutrition, and the Prevention of Chronic Diseases. World Health Organization Technical Report Series 916. Report of a Joint WHO/FAO Expert Consultation, World Health Organization/Food and Agriculture Organization of the United Nations 2003 Available at: http://www.fao.org/DOCREP/005/AC911E/AC911E00.HTM. Accessed March 18, 2010.
  3. Kelishadi R. Childhood overweight, obesity, and the metabolic syndrome in developing countries. Epidemiol Rev. 2007;29:62–76
  4. Sinaiko AR, Jacobs DR, Steinberger J, et al. Insulin resistance syndrome in childhood: associations of the euglycemic insulin clamp and fasting insulin with fatness and other risk factors. J Pediatr. 2001;139:700–707
  5. Cook S, Weitzman M, Auinger P, et al. Prevalence of a metabolic syndrome phenotype in adolescents: findings from the third National Health and Nutrition Examination Survey, 1988–1994. Arch Pediatr Adolesc Med. 2003;157:821–827
  6. Alberti KG, Zimmet P, Shaw J. IDF Epidemiology Task Force Consensus Group: the metabolic syndrome—a new worldwide definition. Lancet. 2005;366:1059–1062
  7. Chen W, Berenson GS. Metabolic syndrome: definition and prevalence in children. J Pediatr. 2007;83:1–2
  8. Franks PW, Hanson RL, Knowler WC, et al. Childhood predictors of young onset type 2 diabetes mellitus. Diabetes. 2007;56:2964–2972
  9. Morrison JA, Friedman LA, Gray-McGuire C. Metabolic syndrome in childhood predicts adult cardiovascular disease 25 years later: the Princeton Lipid Research Clinics Follow-up Study. Pediatrics. 2007;120:340–345
  10. NCEP . National Cholesterol Education Program. Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III): Full Report. Bethesda, MD: National Institutes of Health; 2001;NIH publication No. 01-3670
  11. NCEP. National Cholesterol Education Program Expert Panel on Blood Cholesterol Levels in Children and Adolescents: Cholesterol and Atherosclerosis in Children. 2004. Available online at: http://www.americanheart.org/presenter.jhtml?identifier=4499. Accessed March 18, 2010.
  12. Lambert M, Paradis G, O'Loughlin J, et al. Insulin resistance syndrome in a representative sample of children and adolescents from Quebec, Canada. Int J Obes Relat Metab Disord. 2004;28:833–841
  13. De Ferranti SD, Gauvreau K, Ludwig DS, et al. Prevalence of the metabolic syndrome in American adolescents: findings from the Third National Health and Nutrition Examination Survey. Circulation. 2004;110:2494–2497
  14. NHBPEP: National High Blood Pressure Education Working Group. The fourth report on the diagnosis, evaluation, and treatment of high blood pressure in children and adolescents. Pediatrics. 2004;114:555–576
  15. de Onis M, Onyango AW, Borghi E, Siyam A, Nishida C, Siekmann J. Development of a WHO growth reference for school-aged children and adolescents, Bulletin of the World Health Organization. 2007. Available at: http://www.who.int/bulletin/volumes/85/9/07-043497/en/index.html. Accessed March 18, 2010.
  16. Fernandez JR, Redden DT, Pietrobelli A, et al. Waist circumference percentiles in children and adolescents. J Pediatr. 2004;145:439–444
  17. Trinder P. determination of glucose in blood using glucose oxidase with an alternative receptors. Ann Clin Biochem. 1969;6:24
  18. FAO/WHO/UNU: Food and Agriculture Organization/World Health Organization/United Nation University. Energy and protein requirements. Report of a Joint FAO/WHO/UNU Expert Consultation. Geneva: World Health Organization; 1985;
  19. FAO/WHO, Joint FAO/WHO: Food and Agriculture Organization/World Health Organization. Expert Consultation on Human Vitamin and Mineral Requirements. Geneva: World Health Organization; 2000;
  20. Dryer RL. In: The lipids, Teiz NW, editors. Fundamentals of Clinical Chemistry. Philadelphia: WB Saunders; 1970:329.
  21. Finley PR. Determination of high density lipoprotein (HDL) cholesterol in serum or plasma. Clin Chem. 1978;24:931
  22. Templ RC, Clark PM, Hales CN. Measurement of insulin secretion in type 2 diabetes by ELISA kits: problems and pitfalls. Diabetic Med. 1995;9:503–512
  23. Ueland PM, Refsum H, Stabler SP, Malinow MR, Andersson A, Allen RH. Total homocysteine in plasma or serum. Methods and clinical applications. Clin Chem. 1993;39:1764–1779
  24. Clarke R, Smith AD, Jobst KA, Refsum H, Sutton L, Ueland PM. Folate, vitamin B12, and serum total homocysteine levels in confirmed Alzheimer disease. Arch Neurol. 1998;55:1449–1455
  25. In:  Tietz NW editors. Clinical Guide to Laboratory Tests. 3rd ed. Philadelphia: W.B. Saunders Company; 1995;
  26. Keskin M, Kurtoglu S, Kendirci M, et al. Homeostasis model assessment is more reliable than the fasting glucose/insulin ratio and quantitative insulin sensitivity check index for assessing insulin resistance among obese children and adolescents. Pediatrics. 2004;115:e500–e503
  27. Messiah SE, Carrillo-Iregui A, Garibay-Nieto N, Lopez-Mitnik G, Cossio S, Aheart KL. Prevalence of metabolic syndrome in US-Born Latin and Caribbean Youth. J Immigr Minor Health. 2009;11:1557–1912
  28. Weiss R, Dziura J, Burgert TS, et al. Obesity and the metabolic syndrome in children and adolescents. N Engl J Med. 2004;350:2362–2374
  29. Rodriguez-Moran M, Salazar-Vazquez B, Violante R, et al. Metabolic syndrome among children and adolescents aged 10–18 years. Diabetes Care. 2004;27:2516–2517
  30. Duncan GE, Li SM, Zhou XH. Prevalence and trends of a metabolic syndrome phenotype among U.S. adolescents, 1999–2000. Diabetes Care. 2004;27:2438–2443
  31. Ford ES. Prevalence of the metabolic syndrome defined by the International Diabetes Federation among adults in the U.S. Diabetes Care. 2005;28:2745–2749
  32. IDF: International Diabetes Federation, Prevalence of the Metabolic Syndrome Among U.S. Adolescents Using the Definition From the International Diabetes Federation. 2007. Available at: www.idf.org. Accessed March 18, 2010.
  33. Zimmet P, Alberti G, Kaufman F, et al. International Diabetes Federation Task Force on Epidemiology and Prevention of Diabetes: the metabolic syndrome in children and adolescents. Lancet. 2007;369:2059–2061
  34. Weiss R, Dziura J, Burgert TS, et al. Obesity and the metabolic syndrome in children and adolescents. N Engl J Med. 2004;350:2362–2374
  35. Cruz ML, Weigensberg MJ, Huang TT, Ball G, Shaibi GQ, Goran MI. The metabolic syndrome in overweight Hispanic youth and the role of insulin sensitivity. J Clin Endocrinol Metab. 2004;89:108–113
  36. Esmaillzadeh A, Mirmiran P, Azadbakht L, Etemadi A, Fereidoun A. High prevalence of the metabolic syndrome in Iranian adolescents. Obesity. 2006;14:377–382
  37. Srinivasan S, Meyers , Berenson G. Predictability of childhood adiposity and insulin for developing insulin resistance syndrome (syndrome X) in young adulthood: the Bogalusa Heart Study. Diabetes. 2002;51:204–209
  38. Kelishadi R, Gouya MM, Adeli K, et al. Factors associated with the metabolic syndrome in a national sample of youths: CASPIAN Study. Nutr Metab Cardiovasc Dis. 2008;18:461–470
  39. Agirbasli M, Cakir S, Ozme S, Ciliv G. Metabolic syndrome in Turkish children and adolescents. Metab Clin Exp. 2006;55:1002–1006
  40. Ford ES, Li C, Zhao G, Pearson WS, Mokdad AH. Prevalence of the metabolic syndrome among U.S. adolescents using the definition from the International Diabetes Federation. Diabetes Care. 2008;31:587–589
  41. Jago R, Baranowski T, Buse J, et al. Prevalence of the metabolic syndrome among a racially/ethnically diverse group of U.S. eighth-grade adolescents and associations with fasting insulin and homeostasis model assessment of insulin resistance levels. Diabetes Care. 2008;31:2020–2025
  42. Wang Y, Lobstein T. Worldwide trends in childhood overweight and obesity. Int J Pediatr Obes. 2006;1:11–25
  43. Csábi GY, Török K, Jeges S, et al. Presence of metabolic cardiovascular syndrome in obese children. Eur J Pediatr. 2000;159:91–94
  44. da Silva R, Miranda WL, Chacra AR, Dib SA. Metabolic syndrome and insulin resistance in normal glucose tolerant Brazilian adolescents with family history of type 2 diabetes. Diabetes Care. 2005;28:716–718
  45. Steinberger J, Daniels SR. American Heart Association Atherosclerosis, Hypertension, and Obesity in the Young Committee (Council on Cardiovascular Disease in the Young); American Heart Association Diabetes Committee (Council on Nutrition, Physical Activity, and Metabolism). Obesity, insulin resistance, diabetes, and cardiovascular risk in children: an American Heart Association scientific statement from the Atherosclerosis, Hypertension, and Obesity in the Young Committee (Council on Cardiovascular Disease in the Young) and the Diabetes Committee (Council on Nutrition, Physical Activity, and Metabolism). Circulation. 2003;107:1448–1453
  46. Ekelund U, Anderssen S, Andersen LB, et al. Prevalence and correlates of the metabolic syndrome in a population-based sample of European youth. Am J Clin Nutr. 2009;89:90–96
  47. Ko GT. Metabolic syndrome or “central obesity syndrome?”. Diabetes Care. 2006;29:752
  48. Jessup A, Harrell JS. The metabolic syndrome: look for it in children and adolescents, too!. Clin. Diabetes. 2005;23:26–32
  49. Katzmarzyk P, Srinivasan S, Wei C, Malina R, Bouchard C, Berenson G. Body mass index, waist circumference, and clustering of cardiovascular disease risk factors in a biracial sample of children and adolescents. Pediatrics. 2004;114:E198–E205
  50. Berenson GS, Srinivasan SR, Bao W, Newman WP, Tracy RE, Wattigney WA. Association between multiple cardiovascular risk factors and atherosclerosis in children and young adults. N Engl J Med. 1998;338:1650–1656
  51. Acton KJ, Rios Burrows N, Moore K, Querec L, Geiss LS, Engelgau MM. Trends in diabetes prevalence among American Indian and Alaska native children, adolescents, and young adults. Am J Public Health. 2002;92:1485–1490
  52. Ford ES. C-reactive protein concentration and cardiovascular disease risk factors in children: findings from the National Health and Nutrition Examination Survey 1999–2000. Circulation. 2003;108:1053–1058
  53. Ford ES, Galuska DA, Gillespie C, Will JC, Giles WH, Dietz WH. C-reactive protein and body mass index in children: findings from the Third National Health and Nutrition Examination Survey, 1988–1994. J Pediatr. 2001;138:486–492
  54. Cook DG, Mendall MA, Whincup PH, et al. C-reactive protein concentration in children: relationship to adiposity and other cardiovascular risk factors. Atherosclerosis. 2000;149:139–150
  55. Isasi CR, Deckelbaum RJ, Tracy RP, Starc TJ, Berglund L, Shea S. Physical fitness and C-reactive protein level in children and young adults: the Columbia University BioMarkers Study. Pediatrics. 2003;111:332–338
  56. Wu DM, Chu NF, Shen MH, Chang JB. Plasma C-reactive protein levels and their relationship to anthropometric and lipid characteristics among children. J Clin Epidemiol. 2003;56:94–100
  57. Visser M, Bouter LM, McQuillan GM, Wener MH, Harris TB. Low-grade systemic inflammation in overweight children. Pediatrics. 2001;107:E13

PII: S1933-2874(10)00106-6

doi: 10.1016/j.jacl.2010.03.007

Journal of Clinical Lipidology
Volume 4, Issue 3 , Pages 185-195 , May 2010

Article Tools

* Image Usage & Resolution